期刊文献+

桃核承气改良方对家兔血管内皮损伤后STAT3和VEGF影响的实验研究 被引量:2

Effect of Improved Prescription of Taoren Chengqi Decoction on the Activation of STAT3 and VEGF of Rabbits after Intimadenudation
原文传递
导出
摘要 目的:研究中药桃核承气改良方对家兔血管内皮损伤后STAT3(信号转导和转录活化因子)和VEGF(血管内皮生长因子)的影响。方法:健康新西兰大耳白兔40只,体重2~2.5kg,雌雄不拘。将动物分模型组(n=10)、中药组(n=10)、西药组(n=10)、空白组(n=10),模型组、中药组、西药组高酯饲料喂养4周后行腹主动脉内膜剥脱术造模。术后模型组、中药组、西药组正常饲料喂养,中药组予桃核承气改良方灌胃4周,西药组予舒降之、阿司匹林灌胃4周,模型组、空白组予生理盐水灌胃4周。采用半定量RT-PCR法测定血管中STAT3mRNA半定量和VEGF mRNA半定量。结果:模型组STAT3和VEGF mRNA半定量较空白组明显升高(P〈0.05);西药组STAT3和VEGF mRNA半定量较模型组明显降低(P〈0.05);中药组STAT3和VEGF mRNA半定量较模型组明显降低(P〈0.05),中药组与西药组之间无明显差异(P〉0.05)。结论:桃核承气改良方能防治血管内皮增生从而预防冠心病经皮冠状动脉介入治疗技术后冠脉再狭窄。 Ojective:To investigate the effects of improved proscription of Taoron Chengqi decoction (Peach Kernel decoction for strengthening qi) on the activation of STAT3 and VEGF of rabbits after intimadenudation. Methods :40 healthy New - Zealand white rabbits ( 2 - 2.5 kg) were divided into the model group ( n = 10), Chinese medicine group ( n = 10), western medicine group (n = 10 ), and the narmol group (n = 10 ). Before the operation, model group, Chinese medicine group and western medicine group were feeded with high fat diet for 4 weeks. Afer the operation, model group, Chinese medicine group and western medicine group were fecded with narmol diet for 4 weeks, and the intragastric administration of Chinese medicine group( n = 10) is the improved prescription of Taoron Chengqi decoction, western medicine group is simvastation and asprin. The expression of STAT3 and VEGF mRNA was determined using RT - PCR method. Results :The expression level of STAT3 and VEGF mRNA of model group are higher than the narmol group obviously. The expression level of STAT3 and VEGF mRNA of Chinese medicine group and western medicine group are decreased( Compared with the group of control, P 〈 0.05 ). The Chinese medicine group and western medicine group have no difference ( P 〉 0.05 ). Conclusion:The improved prescription of Taoren Chengqi decoction has an accelerating action on growth and function of vascular endothelial cell. It is effective in the prevention of restenosis after PCI.
出处 《中华中医药学刊》 CAS 2009年第5期1022-1025,共4页 Chinese Archives of Traditional Chinese Medicine
基金 辽宁省教育厅高等学校科学研究项目(05L246)
关键词 桃核承气改良方 血管内膜剥脱术 血管内皮 STAT3 VEGF improved prescription of Taoren Chengqi decoction intimadenudation vascular endothelial STAT3 VEGF
  • 相关文献

参考文献23

  • 1刘占军,徐耕.Cilostazol与经皮冠状动脉介入术后再狭窄的防治[J].国际心血管病杂志,2006,33(3):150-152. 被引量:6
  • 2张勇,娄桂予,钱民章.建立兔高脂血症模型及动脉粥样硬化斑块的方法[J].遵义医学院学报,2001,24(4):304-306. 被引量:47
  • 3Bauters C, Meurice T, Hamon M, et al. Mechanisms and prevention of restenosis : from experimental models to clinical practice [J]. Cardiovasc Res,1996,31 (6) :835 -846.
  • 4Rensing BJ,Vos J,Smits PC,et al. Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6 - month angiographic and intravaseular ultrasonic follow - up[ J]. Eur Heart J ,2001,22(22)2125 -2130.
  • 5Mosea JW, O'Shaughnessy C, Capito R, et al. The US multicenter, randomized, double blind study of the sirolimuseluting stent in coronary lesions: safety out comes at 9 months[ J]. Eur Heart J,2002,23 (Suppl) :264.
  • 6Indolfi C, Mongiardo A, Curoio A, et al. Molecular mechanisms of instent restenosis and app roach to therapywith elutlng stentsl Trends[ J]. Cardiovase Med ,2003,13 : 142 - 148.
  • 7Marks AR. Rapamycin : signaling in vascular smooth muscle[ J]. Transplant Proc ,2003,35 ( Supp 1 3) :231S - 233S.
  • 8Bromberg JF, Wrzeszczynska MH, Devgan G, et al. Stat3 as an oncogen[ J]. Cell, 1999,98 : 295 - 303.
  • 9Damell JE J r. STATs and gene regulation[ J]. Science, 1997, 277 : 1630 - 1635.
  • 10Foshay K,Rodriguez G,Hoel B,et al. JAK2/STATS directscar-diomyogenesis within murine embryonic stem cells in vitro[ J]. Stem Cells,2005,23 : 530 -543.

二级参考文献16

  • 1[1]Kariyazono H,Nakamura K,Shinkawa T,et al.Inhibition of platelet aggregation and the release of P-selectin from platelets by cilostazol[J].Thromb Res,2001,101 (6):445-453.
  • 2[3]Tanabe Y,Ito E,Nakagawa I,et al.Effect of cilostazol on restenosis after coronary angioplasty and stenting in comparison to conventional coronary artery stenting with ticlopidine[J].Int J Cardiol,2001,78(3):285-291.
  • 3[4]Nakamura T,Houchi H,Minami A,et al.Endothelium-dependent relaxation by cilostazol,a phosphodiesteras Ⅲ inhibitor,on rat thoracic aorta[J].Life Sci,2001,69 (15):1709-1715.
  • 4[5]Ito C,Kusano E,Akimoto T,et al.Cilostazol enhances IL1beta-induced NO production and apoptosis in rat vascular smooth muscle via PKA-dependent pathway[J].Cell Signal,2002,14(7):625-632.
  • 5[6]Morishita R.A scientific rationale for the CREST trial results:Evidence for the mechanism of action of cilostazol in restenosis[J].Atheroscler,(Suppl):2005.
  • 6[7]Diep QN,El Mabrouk M,Cohn JS,et al.Structure,endothelial function,cell growth,and inflammation in blood vessels of angiotensin Ⅱ-infused rats:role of peroxisome proliferator-activated receptor-gamma[J].Circulation,2002,105(19):2296-2302.
  • 7[8]Freeman EJ.The Ang Ⅱ-induced growth of vascular smooth muscle cells involves a phospholipase D-mediated signaling mechanism[J].Arch Biochem Biophys,2000,374 (2):363-370.
  • 8[9]Takai S,Jin D,Nishimoto M,et al.Cilostazol suppresses intimal formation in dog grafted veins with reduction of angiotensin Ⅱ-forming enzymes[J].Eur J Pharmacol,2001,411(3):301-304.
  • 9[10]Tsuchikane E,Kobayashi T,Kobayashi T,et al.Debulking and stenting versus debulking only of coronary artery disease in patients treated with cilostazol (final results of ESPRIT)[J].Am J Cardiol,2002,90(6):573-578.
  • 10[11]Tanigawa T,Nishikawa M,Kitai T,et al.Increased platelet aggregability in response to shear stress in acute myocardial infarction and its inhibition by combined therapy with aspirin and cilostazol after coronary intervention[J].Am J Cardiol,2000,85(9):1054-1059.

共引文献49

同被引文献46

引证文献2

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部